Magnus Brisander,Mustafa Demirbüker,Gérald Jesson,Martin Malmsten,Helene Dérand
申请号:
US15791093
公开号:
US10143683B2
申请日:
2017.10.23
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.